Skip to main content
SpringerLink
Log in

Cohort study: major bleeding risk with DOACs vs VKAs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Souverein PC, et al. Comparing risk of major bleeding between users of different oral anticoagulants in patients with non-valvular atrial fibrillation. British Journal of Clinical Pharmacology : 6 Jul 2020. Available from: URL: http://doi.org/10.1111/bcp.14450

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohort study: major bleeding risk with DOACs vs VKAs. Reactions Weekly 1813, 5 (2020). https://doi.org/10.1007/s40278-020-80762-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80762-1

Search

Navigation